This typically includes your current weight, height (to calculate your Body Mass Index or BMI), and any diagnosed health conditions that are related to your weight, such as diabetes, high blood pressure, or sleep apnea
[2] Other GLP-1s have similar profiles
Obesity as a chronic condition In 2013, the American Medical Association recognized obesity as a complex, chronic disease requiring medical attention
Orforglipron (LY3502970) is a non-peptide GLP-1R agonist currently in clinical development that has demonstrated promising effects on glycemic control and body weight reduction, highlighting the continued expansion of GLP-1-based therapeutic strategies [4]
Exenatide lowers HbA1c and postprandial glucose, with the once-weekly regimen demonstrating greater efficacy compared to the twice-daily option [74]
Once opened, both can typically be stored at room temperature for a limited period (28 days for most products)